Serum Institute qHPV vaccine against cervical cancer to be launched by year-end, says Adar Poonawalla - Video

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an range of Rs 200-400, Serum Institute of India CEO Adar Poonawalla said on Thursday.

Speaking at an event held to announce the scientific completion of the vaccine, Union Minister of Science and Technology Jitendra Singh said the vaccine will be affordable and the government will ensure that it is accessible to the common man.

For more details, check out the link given below:

SII qHPV vaccine against cervical cancer to be launched by year-end, to be priced between Rs 200-400: Adar Poonawalla